If there was one “most valuable player” that everyone in medical settings relied on during the pandemic, many would name personal protective equipment (PPE). However, while the lack of proper equipment has been felt acutely in every facility, the problem is not yet solved six months into COVID-19, with experts predicting that shortages could persist for years to come.
If there’s one thing that incubators know how to do, it’s innovate. Therefore, it should come as no surprise that while the global pandemic provided challenges for everyone in every industry, incubators were able to find creative ways to survive and thrive.
A recent panel presentation brought together a number of speakers associated with all aspects of the incubator ecosystem,
Reimagining work will help lead us into a new chapter and beyond.
As some states begin to loosen their guidelines, many employees now will have the ability to move from shelter-in-place back to their offices. This remobilization has been referred to by many as “re-entry.”
But we will not be entering the same workspace in the same way;
As we look ahead to the eventual easing of shelter-in-place requirements, companies are considering how to tackle the next phase of re-entry. Recently, we had the pleasure of hearing from Denise Zarins, Zach Edmonds, MD, and Gayle Kuokka, the dedicated re-entry leads for the Fogarty Institute, who held a collaborative discussion with our companies-in-residence and outside healthtech startups.
Countless lives in the community and around the world have been touched by Pamela and Edward (Ed) Taft, who have made philanthropy the cornerstone of their daily lives. By generously contributing to causes they are passionate about in multiple broad areas—education, the environment and healthcare, to name three—they continue to make a lasting and profound impact.
When Neil Ray, MD, founder and CEO of FII graduate Raydiant Oximetry and a board-certified anesthesiologist, learned about the global shortage of ventilators early in the COVID-19 crisis, he immediately considered ways that he, his colleagues and others in the Silicon Valley medtech ecosystem could help.
He first reached out to Russ DeLonzor,
As the Medical Device Manufacturers Association (MDMA) continues to take the lead in representing the interest of medtech companies, we wanted to sit down and talk with president and CEO, and Fogarty Institute board member, Mark Leahey, about the current landscape. MDMA is an incredibly nimble and effective organization – just like its constituents – and has been a beacon during the COVID-19 crisis,
Innovation can’t be stopped by a quarantine. The 2020 annual UCSF-Stanford Pediatric Device Consortium Pitch Competition, originally scheduled to take place at the Stanford University School of Medicine, went off seamlessly in a virtual, but still highly interactive format last month.
The Pediatric Device Consortium (PDC) felt it was critical to hold the competition as planned in order to support the much-needed development of health technologies for children,
When you’ve weathered adversity and come through on the other side, you bring a new perspective that can be helpful to those encountering a similar challenge for the first time. That’s why we turned to Allan Will for some advice based on his strong track record of founding, running, building and selling medical device companies,
While COVID-19 has presented extraordinary challenges globally, no one has felt it more acutely than those on the frontline, our incredibly brave healthcare workers. El Camino Health has been at the forefront of this crisis in an effort to stay ahead of the curve and prepare not only its own hospitals, but others in the area to best support Bay Area patients.